Literature DB >> 27651100

Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.

Kashappa Goud Desai1.   

Abstract

The objective of this review is to summarize recent advances in chitosan nanoparticles prepared by ionotropic gelation. Significant progress has occurred in this area since the method was first reported. The gelation technique has been improved through a number of creative methodological modifications. Ionotropic gelation via electrospraying and spinning disc processing produces nanoparticles with a more uniform size distribution. Large-scale manufacturing of the nanoparticles can be achieved with the latter approach. Hydrophobic and hydrophilic drugs can be simultaneously encapsulated with high efficiency by emulsification followed by ionic gelation. The turbulent mixing approach facilitates nanoparticle formation at a relatively high polymer concentration (5 mg/mL). The technique can be easily tuned to achieve the desired polymer/surface modifications (e.g., blending, coating, and surface conjugation). Using factorial-design-based approaches, optimal conditions for nanoparticle formation can be determined with a minimum number of experiments. New insights have been gained into the mechanism of chitosan-tripolyphosphate nanoparticle formation. Chitosan nanoparticles prepared by ionotropic gelation tend to aggregate/agglomerate in unfavorable environments. Factors influencing this phenomenon and strategies that can be adopted to minimize the instability are discussed. Ionically cross-linked nanoparticles based on native chitosan and modified chitosan have shown excellent efficacy for controlled and targeted drug-delivery applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27651100     DOI: 10.1615/CritRevTherDrugCarrierSyst.2016014850

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  19 in total

1.  Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.

Authors:  Zi Chao Wu; Xin Yu Liu; Jia Yan Liu; Jing Shu Piao; Ming Guan Piao
Journal:  Int J Nanomedicine       Date:  2022-09-14

2.  Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.

Authors:  Ye Liang; Yonghua Wang; Liping Wang; Zhijuan Liang; Dan Li; Xiaoyu Xu; Yuanbin Chen; Xuecheng Yang; Hongbo Zhang; Haitao Niu
Journal:  Bioact Mater       Date:  2020-09-08

3.  Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.

Authors:  Sylvie Skalickova; Martin Loffelmann; Michael Gargulak; Marta Kepinska; Michaela Docekalova; Dagmar Uhlirova; Martina Stankova; Carlos Fernandez; Halina Milnerowicz; Branislav Ruttkay-Nedecky; Rene Kizek
Journal:  Nanomaterials (Basel)       Date:  2017-12-08       Impact factor: 5.076

Review 4.  Ionotropic Gelation of Chitosan Flat Structures and Potential Applications.

Authors:  Pasquale Sacco; Seidy Pedroso-Santana; Yogesh Kumar; Nicolas Joly; Patrick Martin; Patrizia Bocchetta
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

5.  Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.

Authors:  Christopher J Genito; Cole J Batty; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Nanobiomed Res       Date:  2021-01-18

6.  Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.

Authors:  Xiaoyi Gao; Nan Liu; Zengming Wang; Jing Gao; Hui Zhang; Meng Li; Yimeng Du; Xiang Gao; Aiping Zheng
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

7.  Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.

Authors:  Jonathan Wang; Deborah Chin; Christopher Poon; Valeria Mancino; Jessica Pham; Hui Li; Pei-Yin Ho; Kenneth R Hallows; Eun Ji Chung
Journal:  J Control Release       Date:  2020-10-28       Impact factor: 9.776

Review 8.  Nanoparticles as a Solution for Eliminating the Risk of Mycotoxins.

Authors:  Pavel Horky; Sylvie Skalickova; Daria Baholet; Jiri Skladanka
Journal:  Nanomaterials (Basel)       Date:  2018-09-14       Impact factor: 5.076

9.  Chitosan-Polylactide/Hyaluronic Acid Complex Microspheres as Carriers for Controlled Release of Bioactive Transforming Growth Factor-β1.

Authors:  Qing Min; Jiaoyan Liu; Jing Li; Ying Wan; Jiliang Wu
Journal:  Pharmaceutics       Date:  2018-11-17       Impact factor: 6.321

10.  The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency.

Authors:  Arianna Gennari; Julio M Rios de la Rosa; Erwin Hohn; Maria Pelliccia; Enrique Lallana; Roberto Donno; Annalisa Tirella; Nicola Tirelli
Journal:  Beilstein J Nanotechnol       Date:  2019-12-30       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.